- Home
- CHR vs NXL Comparison
CHR vs NXL Comparison
Compare CHR & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- NXL
- Stock Information
- Founded
- CHR 2016
- NXL 2010
- Country
- CHR China
- NXL United States
- Employees
- CHR N/A
- NXL N/A
- Industry
- CHR EDP Services
- NXL Medical Specialities
- Sector
- CHR Technology
- NXL Health Care
- Exchange
- CHR Nasdaq
- NXL Nasdaq
- Market Cap
- CHR 12.9M
- NXL 14.0M
- IPO Year
- CHR N/A
- NXL 2022
- Fundamental
- Price
- CHR $1.18
- NXL $1.02
- Analyst Decision
- CHR
- NXL Strong Buy
- Analyst Count
- CHR 0
- NXL 1
- Target Price
- CHR N/A
- NXL $5.00
- AVG Volume (30 Days)
- CHR 87.5K
- NXL 2.4M
- Earning Date
- CHR 07-30-2025
- NXL 08-06-2025
- Dividend Yield
- CHR N/A
- NXL N/A
- EPS Growth
- CHR N/A
- NXL N/A
- EPS
- CHR 1.76
- NXL N/A
- Revenue
- CHR $147,134,000.00
- NXL $174,813.00
- Revenue This Year
- CHR N/A
- NXL $79.59
- Revenue Next Year
- CHR N/A
- NXL $334.65
- P/E Ratio
- CHR $0.67
- NXL N/A
- Revenue Growth
- CHR N/A
- NXL 16.42
- 52 Week Low
- CHR $1.00
- NXL $0.59
- 52 Week High
- CHR $3.45
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- CHR 37.15
- NXL 56.83
- Support Level
- CHR $1.08
- NXL $0.70
- Resistance Level
- CHR $2.03
- NXL $0.84
- Average True Range (ATR)
- CHR 0.09
- NXL 0.10
- MACD
- CHR -0.03
- NXL 0.00
- Stochastic Oscillator
- CHR 13.16
- NXL 60.23
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.